iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionSculati Wealth Management, LLC
Latest Disclosed Ownership1,895 shares
Latest Disclosed Value $ 319,971
Sculati Wealth Management, LLC reports 30.59% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 9, 2026 - Sculati Wealth Management, LLC filed a 13F-HR form disclosing ownership of 1,895 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $319,971 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,730 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -30.59% during the quarter. The current value of the position is $248,340 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,895 -835 -30.59 320 -30.65 0.1181
2026-02-05 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,730 -135 -4.71 461 11.38 0.1624
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,865 -1,009 -26.05 414 -15.71 0.1458
2025-08-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,874 -1,475 -27.58 490 -28.36 0.1841
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,349 -562 -9.51 684 -12.42 0.2766
2025-02-26 2024-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 5,911 -174 -2.86 781 -11.75 0.3089
2025-02-05 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,530 0 1,582 0.6824
2025-02-26 2024-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 6,085 -3,441 -36.12 886 -32.29 0.3534
2024-11-22 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,530 2,004 1,582 0.6824
2024-08-09 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 9,526 -2,004 -17.38 1,308 -17.38 0.5586
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,530 -3,323 -22.37 1,582 -21.57 0.6824
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,853 -40 -0.27 2,018 10.76 0.9400
2023-11-09 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,893 1,077 7.80 1,821 3.82 0.9307
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,816 -14 -0.10 1,754 -1.79 0.8826
2023-05-05 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,830 63 0.46 1,786 178,500.00 0.9487
2023-02-10 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,767 -377 -2.67 2 -99.94 1.0152
2022-11-15 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,144 233 1.67 1,654 1.10 0.9766
2022-08-09 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,911 175 1.27 1,636 -8.60 0.9339
2022-05-10 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,736 280 2.08 1,790 -12.85 0.8748
2022-02-07 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,456 287 2.18 2,054 -3.52 0.9927
2021-11-02 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,169 103 0.79 2,129 -0.42 1.1280
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,066 0 0.00 2,138 8.69 1.1328
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 13,066 70 0.54 1,967 -0.10 1.1331
2021-02-10 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,996 240 1.88 1,969 14.01 1.2931
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,756 302 2.42 1,727 1.47 1.2930
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,454 417 3.46 1,702 31.23 1.4355
2020-05-22 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 12,037 621 5.44 1,297 -5.74 1.4263
2020-02-13 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 11,416 11,416 1,376 1.2338
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.